Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.
You will only be able to see the first 20 seconds.

Paramyxoviruses for Tumor-targeted Immunomodulation
 

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Article doi: 10.3791/58651
January 7th, 2019

Summary January 7th, 2019

This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter